CERRITOS, CA--(Marketwired - Oct 12, 2015) - The partnership between Rutgers School of Dental Medicine and Millennium Dental Technologies, Inc. (MDT) reached another milestone. On Friday, August 7, three doctors from the esteemed Rutgers University Postgraduate Periodontics program completed their next phase of training, Evolution 4, on the PerioLase® MVP-7™ and the LANAP® and LAPIP™ protocols. Andrew Sullivan, DDS, director of postgraduate periodontics and interim chairman; Howard Drew, DMD, clinical professor of periodontics, director of implantology, and vice chairman of the department of periodontics; and Joel Pascuzzi, DMD, FIDC, FADC, clinical professor of periodontics and the director of the pre-doctorate periodontal program, completed the first phase of training with theInstitute for Advanced Laser Dentistry (IALD) earlier this year in February.
This groundbreaking partnership, the first-ever educational collaboration agreement with a university incorporating the LANAP® and LAPIP™ protocols, allows the Rutgers team to expand its periodontal curriculum, maintaining a long-standing tradition of being among the top schools in the country to offer the best dental education possible.
The IALD's 12-month training continuum consists of five days of training on the patented LANAP® and LAPIP™ treatment protocols. During Evolution 4, Drs. Drew, Sullivan and Pascuzzi treated a live patient under the direction of a certified IALD instructor and learned optimal LANAP® protocol techniques, methodology, and laser operating parameters. Once their training is complete, the doctors will be certified IALD instructors, able to train other doctors on the LANAP® and LAPIP™ protocols at Rutgers. "The LANAP® protocol is really quite amazing,'' said Dr. Sullivan. "Patients are thrilled with it."
At the heart of this specialized training program is the LANAP® protocol with the PerioLase® MVP-7™, the only U.S. FDA-cleared laser periodontitis treatment with any scientific evidence of regenerating periodontal ligament attachment to the root surface and a new root coating (cementum). In addition, there are more than 400 published positive patient outcomes and two histology studies. The PerioLase® MVP-7™ is also developed for the LAPIP™ protocol, for the minimally invasive surgical treatment for peri-implantitis and mucositis around ailing and failing implants.